Senseonics Holdings (SENS) Total Current Liabilities (2014 - 2026)
Senseonics Holdings' (SENS) quarterly Total Current Liabilities came in at $26.3 million in Q1 2026, up 131.25% year-on-year from $11.4 million in Q1 2025, and up 8.12% on a QoQ basis from $24.3 million in Q4 2025.
Senseonics Holdings (SENS) Total Current Liabilities (2014 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 13 years of Total Current Liabilities data on file, last reported at $26.3 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 131.25% year-over-year to $26.3 million in Q1 2026; TTM through Mar 2026 was $26.3 million, a 131.25% increase from a year earlier, with the FY2025 full-year figure at $24.3 million, down 37.33% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $26.3 million, up from $24.3 million in the prior quarter.
- Over the last five years, Total Current Liabilities for SENS reached as high as $57.6 million in Q3 2022 and fell as low as $11.4 million in Q1 2025.
- Historically, Total Current Liabilities has averaged $26.6 million across 5 years, with a median of $26.3 million in 2026.
- Across the five-year window, Total Current Liabilities jumped 189.82% in 2022 and plunged 69.99% in 2023, its largest moves.
- Year by year, Total Current Liabilities stood at $31.5 million in 2022, then slumped by 45.17% to $17.3 million in 2023, then soared by 125.12% to $38.8 million in 2024, then slumped by 37.33% to $24.3 million in 2025, then grew by 8.12% to $26.3 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $26.3 million in Q1 2026, $24.3 million in Q4 2025, and $21.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Senseonics Holdings | 203.54 Mn | 139.22 Mn | 6.94 Mn | 26.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.33 Mn |
| Dec 31, 2025 | 24.35 Mn |
| Sep 30, 2025 | 21.07 Mn |
| Jun 30, 2025 | 14.78 Mn |
| Mar 31, 2025 | 11.38 Mn |
| Dec 31, 2024 | 38.85 Mn |
| Sep 30, 2024 | 35.51 Mn |
| Jun 30, 2024 | 33.12 Mn |
| Mar 31, 2024 | 29.82 Mn |
| Dec 31, 2023 | 17.26 Mn |
| Sep 30, 2023 | 17.30 Mn |
| Jun 30, 2023 | 15.86 Mn |
| Mar 31, 2023 | 14.28 Mn |
| Dec 31, 2022 | 31.47 Mn |
| Sep 30, 2022 | 57.65 Mn |
| Jun 30, 2022 | 31.47 Mn |
| Mar 31, 2022 | 31.48 Mn |
| Dec 31, 2021 | 18.39 Mn |
| Sep 30, 2021 | 19.89 Mn |
| Jun 30, 2021 | 20.02 Mn |